Nabriva Therapeutics PLC - ADR (NBRV) stock is down -82.35% over the last 12 months, and the average rating from Wall Street analysts is a Strong Sell. InvestorsObserver’s proprietary ranking system, gives NBRV stock a score of 22 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 10. NBRV's rank also includes a long-term technical score of 19. NBRV has an Overall Score of 22. Find out what this means to you and get the rest of the rankings on NBRV!